Quantum Biopharma (QNTM) Cash & Equivalents (2018 - 2026)
Quantum Biopharma (QNTM) recorded Cash & Equivalents of $3.65 million in Q2 2026, up 143.5% from $1.5 million a year earlier but down 16.0% from the prior quarter.
Quantum Biopharma (QNTM) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2025, Quantum Biopharma reported Cash & Equivalents of $1.91 million, down 68.2% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -35.8% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $6 million in FY2024 (+117.5%), $2.76 million in FY2023 (-83.8%), $16.98 million in FY2022 (-51.8%) and $35.26 million in FY2021 (+101.2%).
- Quarterly Cash & Equivalents has ranged from $445,944 in Q3 2025 to $39.32 million in Q3 2021 over the past five years.
- On a year-over-year basis, Cash & Equivalents rose in four of the last eight quarters, with growth averaging 28.3%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 180.8% in Q3 2021, against a decline of 85.7% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $4.34 million (Q1 2026), $1.91 million (Q4 2025) and $445,944 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Quantum Biopharma | 13.37 Mn | 1.18 Mn | - | 3.65 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.65 Mn |
| Mar 31, 2026 | 4.34 Mn |
| Dec 31, 2025 | 1.91 Mn |
| Sep 30, 2025 | 445,944.00 |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 3.52 Mn |
| Dec 31, 2024 | 6.00 Mn |
| Sep 30, 2024 | 3.12 Mn |
| Jun 30, 2024 | 3.31 Mn |
| Mar 31, 2024 | 1.33 Mn |
| Dec 31, 2023 | 2.76 Mn |
| Sep 30, 2023 | 3.63 Mn |
| Jun 30, 2023 | 5.67 Mn |
| Mar 31, 2023 | 9.22 Mn |
| Dec 31, 2022 | 16.98 Mn |
| Sep 30, 2022 | 23.75 Mn |
| Jun 30, 2022 | 31.62 Mn |
| Mar 31, 2022 | 28.57 Mn |
| Dec 31, 2021 | 35.26 Mn |
| Sep 30, 2021 | 39.32 Mn |
Quantum Biopharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=QNTM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "QNTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=QNTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();